Notis-McConarty Edward’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.29M | Buy |
7,381
+106
| +1% | +$47.2K | 1.6% | 24 |
|
2025
Q1 | $3.53M | Buy |
7,275
+756
| +12% | +$367K | 1.81% | 23 |
|
2024
Q4 | $2.63M | Buy |
6,519
+1,257
| +24% | +$506K | 1.27% | 27 |
|
2024
Q3 | $2.45M | Buy |
5,262
+1,475
| +39% | +$686K | 1.11% | 30 |
|
2024
Q2 | $1.78M | Buy |
3,787
+2,462
| +186% | +$1.15M | 0.7% | 39 |
|
2024
Q1 | $554K | Buy |
+1,325
| New | +$554K | 0.22% | 65 |
|